Merck Appoints Simon Sturge as New Head of Biosimilars Unit
[at noodls] – Darmstadt, Germany, February 20, 2014 – Merck announced today that Simon Sturge (54) will join the company from Boehringer Ingelheim effective March 1, 2014, to head the biosimilars unit. In his new role … moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click […]